Shandong Tumor Hospital

This study is for people with advanced stomach cancer that has gotten worse after their first treatment. It will test if adding two new drugs (adebrelimab and famitinib) to a standard chemotherapy drug (irinotecan) works better and is safe compared to using the chemotherapy drug …

This study is testing whether combining two existing drugs, carilizumab and albumin paclitaxel, can help control advanced stomach cancer that has worsened after initial treatment. It will enroll 40 adults whose cancer progressed despite first-line chemotherapy, with or without pr…